Literature DB >> 25412339

HIV reservoir dynamics in the face of highly active antiretroviral therapy.

Cecilia T Costiniuk1, Mohammad-Ali Jenabian.   

Abstract

Upon discontinuation of highly active antiretroviral therapy (HAART), human immunodeficiency virus (HIV)-infected individuals experience a brisk rebound in blood plasma viremia due to the exodus of HIV from various body reservoirs. Assessment of HIV dynamics during HAART and following treatment discontinuation is essential to better understand HIV persistence. Here we will first provide a brief overview of the molecular mechanisms involved in HIV reservoir formation and persistence. After a summary of HAART-mediated HIV decay within peripheral blood, we discuss findings from clinical studies examining the effects of HAART initiation and interruption on HIV reservoir dynamics in major anatomical compartments, including lymph nodes and spleen, gut associated lymphoid tissue, reproductive organs, the central nervous system, and the lungs. Features contributing to these reservoirs as distinct compartments, including anatomical features, the presence of drug transporters, and the effect of co-infection, are also discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25412339     DOI: 10.1089/apc.2014.0173

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  15 in total

1.  Identification, Localization, and Quantification of HIV Reservoirs Using Microscopy.

Authors:  Lisa Prevedel; Nancy Ruel; Paul Castellano; Carla Smith; Shaily Malik; Courtney Villeux; Morgane Bomsel; Susan Morgello; Eliseo A Eugenin
Journal:  Curr Protoc Cell Biol       Date:  2018-09-28

2.  Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.

Authors:  Dionna W Williams; Elizabeth L Engle; Erin N Shirk; Suzanne E Queen; Lucio Gama; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  Am J Pathol       Date:  2016-06-18       Impact factor: 4.307

3.  Pericytes as novel targets for HIV/SIV infection in the lung.

Authors:  Sarah E Stephenson; Carole L Wilson; Nell G Bond; Amitinder Kaur; Xavier Alvarez; Cecily C Midkiff; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

4.  Impact of HIV infection on α1-antitrypsin in the lung.

Authors:  Sarah E Stephenson; Carole L Wilson; Kristina Crothers; Engi F Attia; Cherry Wongtrakool; Irina Petrache; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

Review 5.  Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns.

Authors:  Ameer Abutaleb; Sarah Kattakuzhy; Shyam Kottilil; Erin O'Connor; Eleanor Wilson
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

6.  HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.

Authors:  Fabrizio Ensoli; Aurelio Cafaro; Anna Casabianca; Antonella Tripiciano; Stefania Bellino; Olimpia Longo; Vittorio Francavilla; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Maria R Pavone Cossut; Angela Arancio; Chiara Orlandi; Leonardo Sernicola; Maria T Maggiorella; Giovanni Paniccia; Cristina Mussini; Adriano Lazzarin; Laura Sighinolfi; Guido Palamara; Andrea Gori; Gioacchino Angarano; Massimo Di Pietro; Massimo Galli; Vito S Mercurio; Francesco Castelli; Giovanni Di Perri; Paolo Monini; Mauro Magnani; Enrico Garaci; Barbara Ensoli
Journal:  Retrovirology       Date:  2015-04-29       Impact factor: 4.602

7.  Efficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdA.

Authors:  Uma Shanmugasundaram; Martina Kovarova; Phong T Ho; Nathaniel Schramm; Angela Wahl; Michael A Parniak; J Victor Garcia
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

8.  PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread.

Authors:  Xiaolong Tang; Yong Liang; Xinkuang Liu; Shuping Zhou; Liang Liu; Fujina Zhang; Chunmei Xie; Shuyu Cai; Jia Wei; Yongqiang Zhu; Wei Hou
Journal:  Nanoscale Res Lett       Date:  2015-10-22       Impact factor: 4.703

Review 9.  Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.

Authors:  Lijun Zhang; Xiaofang Jia; Jun-O Jin; Hongzhou Lu; Zhimi Tan
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-04-06       Impact factor: 7.691

10.  HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim.

Authors:  Paul Castellano; Lisa Prevedel; Eliseo A Eugenin
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.